Latest News about MRK
Recent news which mentions MRK
From Motley Fool
From Benzinga
Should Investors Buy Merck Stock After These Huge Risks?
April 30, 2025
Tickers
MRK
From Motley Fool
Stock Market Crash: 3 High-Yielding Dividend Stocks Near Their 52-Week Lows to Buy Right Now
April 30, 2025
From Motley Fool
9 Health Care Stocks Whale Activity In Today's Session
April 28, 2025
From Benzinga
Why Is Summit Therapeutics Stock Trading Higher On Monday?
April 28, 2025
From Benzinga
Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion
April 28, 2025
From Benzinga
2 Outstanding Dividend Stocks to Buy and Hold For 20 Years
April 26, 2025
From Motley Fool
From Benzinga
What's Going On With Summit Therapeutics Stock On Friday?
April 25, 2025
From Benzinga
From Benzinga
Merck's Q1 Earnings Beat Wall Street, Adjusts 2025 Profit Outlook As Tariffs May Result In Incremental Cost Of $200 Million
April 24, 2025
From Benzinga
From Benzinga
Earnings Scheduled For April 24, 2025
April 24, 2025
From Benzinga
Why Is Summit Therapeutics Stock Soaring On Wednesday?
April 23, 2025
From Benzinga
Gilead Cancer Drug Combined With Merck's Drug Effective In Difficult To Treat Type Of Breast Cancer
April 21, 2025
From Benzinga
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
April 21, 2025
From Benzinga
Why Merck, Black Hills, And Virtus Investment Partners Are Winners For Passive Income
April 18, 2025
From Benzinga
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot
April 18, 2025
From Benzinga
Where Will Eli Lilly Be in 5 Years?
April 18, 2025
From Motley Fool
Price Over Earnings Overview: Merck & Co
April 15, 2025
From Benzinga
Merck Signs Nearly $500 Million Licensing Deal With Austria-Based Cyprumed For Tablet-Based Peptide Delivery
April 15, 2025
From Benzinga
Marjorie Taylor Greene Made Large Stock Purchases Ahead Of Trump's 90-Day Tariff Pause: Hakeem Jeffries Calls It 'Problematic'
April 15, 2025
From Benzinga
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
April 11, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.